New milestone in the Horizon2020 project

We are happy to announce a new milestone in the Horizon2020 project: the first patient samples have arrived and are measured at the SkylineDx lab.
Read More

New MM treatment gains funding

5 October 2016 New MM treatment gains funding SkylineDx has received Horizon 2020 funding to develop a gene-expression profiling technology intended to predict treatment strategies for patients with multiple myeloma (MM). The announcement comes as SkylineDx prepares...
Read More

Project Partners

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 701143
© MM Predict